SCHEMBL474712

SCHEMBL474712

CS(=O)(=O)OC1CCC(N2CC[C@@H](Cc3c(Cl)cc(OCc4ccccc4)cc3Cl)C2=O)CC1

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 2/20 0.43
HRH3 Q9Y5N1 4/20 0.39
SPHK1 Q9NYA1 4/20 0.38
SPHK2 Q9NRA0 2/20 0.38
NPC1 O15118 1/20 0.36
RAB9A P51151 1/20 0.36
CYP2D6 P10635 2/20 0.36
PRMT5 O14744 1/20 0.36
S1PR1 P21453 1/20 0.36
PRKX P51817 1/20 0.36
ACVR1 Q04771 1/20 0.36
S1PR5 Q9H228 1/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
KDM4C Q9H3R0 1/20 0.35
LMNA P02545 1/20 0.35
MCHR1 Q99705 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL474714 1.00 HSD11B1 (0.43) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL474713 1.00 HSD11B1 (0.43) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL209168 0.89 HSD11B1 (0.47) HSD11B1HRH3NPC1RAB9ACYP2D6
SCHEMBL209167 0.89 HSD11B1 (0.47) HSD11B1HRH3NPC1RAB9ACYP2D6
SCHEMBL209166 0.89 HSD11B1 (0.47) HSD11B1HRH3NPC1RAB9ACYP2D6
SCHEMBL209337 0.87 HSD11B1 (0.48) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL209338 0.87 HSD11B1 (0.48) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL210102 0.87 HSD11B1 (0.48) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL2989845 0.87 HSD11B1 (0.48) HSD11B1HRH3SPHK1SPHK2NPC1
SCHEMBL209336 0.87 HSD11B1 (0.48) HSD11B1HRH3SPHK1SPHK2NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2049475-B1 CYCLOHEXYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 LILLY CO ELI (US) 2012-02-01 EP disclosed
US-7998999-B2 Cyclohexyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 ELI LILLY AND COMPANY (US) 2011-08-16 US disclosed
US-20090239911-A1 CYCLOHEXYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 ELI LILLY AND COMPANY 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239911-A1 CYCLOHEXYL SUBSTITUTED PYRROLIDINONES AS INHIBITORS OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE 1 HSD11B1, HSD17B1, HSD3B1 HSD11B1 1/4885HRH3 3453/4885SPHK1 368/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.